80
Y. Jiang et al. · An Efficient Ultrasound-assisted Method for the Synthesis of 1,4-Disubstituted Triazoles
121.9, 120.8, 114.4, 111.8, 63.1, 55.7, 54.0. – MS (ESI): 2H, 12, 16-H), 6.91 (d, J = 9.2 Hz, 2H, 2, 6-H), 6.83 (d,
m/z (%) = 296 (100) [M+H]+. – HRMS ((+)-ESI): m/z = J = 9.2 Hz, 2H, 3, 5-H), 5.54 (s, 2H, 10-H), 5.15 (s, 2H,
296.1404 (calcd. 296.1399 for C17H18N3O2, [M+H]+).
7-H), 3.77 (s, 3H, -OMe). – 13C NMR (100 MHz, CDCl3):
δ = 154.2, 152.3, 144.7, 134.6, 129.1, 128.7, 128.1, 122.8,
115.9, 114.6, 62.7, 55.6, 54.1. – MS (ESI): m/z (%) = 296
(100) [M+H]+. – HRMS ((+)-ESI): m/z = 296.1397 (calcd.
296.1399 for C17H18N3O2, [M+H]+).
4-[(2-Methoxyphenoxy)methyl]-1-phenyl-1,2,3-triazole (5)
M. p. 130 – 132 ◦C. – IR (KBr): νmax (cm−1) = 3150,
3084, 2955, 2922, 2876, 2835, 1385, 1592, 1503, 1465,
1250, 1218, 1126, 1024. – 1H NMR (400 MHz, CDCl3):
δ = 8.10 (s, 1H, 9-H), 7.74 – 7.72 (dd, J = 1.2, 7.6 Hz,
2H, 11, 15-H), 7.53 (t, J = 7.6 Hz, 2H, 12, 14-H), 7.45 (t,
J = 7.6 Hz, 1H, 13-H), 7.12 – 7.10 (dd, J = 1.6, 8.0 Hz,
1H, 3-H), 6.99 – 6.96 (dd, J = 1.6, 8.0 Hz, 1H, 5-H),
6.94 – 6.92 (m, 2H, 4, 6-H), 5.39 (s, 2H, 7-H), 3.90 (s,
3H, -OMe). – 13C NMR (100 MHz, CDCl3): δ = 149.5,
147.5, 145.1, 137.0 , 129.8, 128.8, 122.0, 121.1, 120.9,
120.6, 114.2, 111.2, 63.1, 55.9. – MS (ESI): m/z (%) = 282
(100) [M+H]+. – HRMS((+)-ESI): m/z = 282.1243 (calcd.
282.1238 for C16H16N3O2, [M+H]+).
1-Benzyl-4-[(2-nitrophenoxy)methyl]-1,2,3-triazole (9)
M. p. 107 – 108 ◦C. – IR (KBr): νmax (cm−1) = 3151,
3088, 3056, 2928, 1616, 1585, 1456, 1529, 1340, 1274,
1
1161, 1045. – H NMR (400 MHz, CDCl3): δ = 7.85 (dd,
J= 1.6, 8.1 Hz, 1H, 3-H), 7.67 (s, 1H, 9-H), 7.58 – 7.53 (td,
J = 1.6, 7.6, 8.0 Hz, 1H, 5-H), 7.40 – 7.37 (m, 3H, 13, 14,
15-H), 7.30 – 7.27 (m, 3H, 6, 12, 16-H), 7.07 (td, J = 1.2,
7.6 Hz, 1H, 4-H), 5.55 (s, 2H, 10-H), 5.37 (s, 2H, 7-H). –
13C NMR (100 MHz, CDCl3): δ = 151.5, 143.6, 140.0,
134.5, 134.3, 129.1, 128.8, 128.0, 125.6, 123.3, 121.1, 115.4,
63.7, 54.2. – MS (ESI): m/z (%) = 311 (100) [M+H]+. –
HRMS ((+)-ESI): m/z = 311.1149 (calcd. 311.1144 for
C16H15N4O3, [M+H]+).
1-Benzyl-4-[(3-methoxyphenoxy)methyl]-1,2,3-triazole (6)
M. p. 84 – 86 ◦C. – IR (KBr): νmax (cm−1) = 3138, 3093,
2933, 2875, 1384, 1596, 1495, 1462, 1231, 1193, 1121,
1053, 1024, 1012. – 1H NMR (400 MHz, CDCl3): δ =
7.54 (s, 1H, 9-H), 7.40 – 7.38 (m, 3H, 13, 14, 15-H), 7.30 –
7.28 (dd, J = 2.4, 7.2 Hz, 2H, 12, 16-H), 7.19 (t, J =
8.4 Hz, 1H, 5-H), 6.59 – 6.53 (m, 3H, 2, 4, 6-H), 5.55 (s,
2H, 10-H), 5.18 (s, 2H, 7-H), 3.78 (s, 3H, -OMe). – 13C
NMR (100 MHz, CDCl3): δ = 160.8, 159.5, 44.5, 134.5,
130.0, 129.1, 128.8, 128.1, 122.8, 107.0, 106.8, 101.2, 62.0,
55.3, 54.2. – MS (ESI): m/z (%) = 296 (100) [M+H]+. –
HRMS ((+)-ESI): m/z = 296.1397 (calcd. 296.1399 for
C17H18N3O2, [M+H]+).
1-Benzyl-4-[(4-nitrophenoxy)methyl]-1,2,3-triazole (10)
M. p. 103 – 104 ◦C. – IR (KBr): νmax (cm−1) = 3147,
3116, 1606, 1494, 1337, 1267, 1114, 1055. – 1H NMR
(400 MHz, CDCl3): δ = 8.21 (d, J = 9.2 Hz, 2H, 3, 5-H), 7.57
(s, 1H, 9-H), 7.42 – 7.39 (m, 3H, 13, 14, 15-H), 7.31 – 7.27
(dd, J = 3.2, 7.6 Hz, 2H, 12, 16-H), 7.07 (d, J = 9.2 Hz, 2H,
2, 6-H), 5.57 (s, 2H, 10-H), 5.28 (s, 2H, 7-H). – 13C NMR
(100 MHz, CDCl3): δ = 163.2, 143.0, 141.7, 134.4, 129.2,
128.9, 128.2, 125.9, 123.3, 114.8, 62.4, 54.3. – MS (ESI):
m/z (%) = 311 (100) [M+H]+. – HRMS ((+)-ESI): m/z =
311.1148 (calcd. 311.1144 for C16H15N4O3, [M+H]+).
4-[(3-Methoxyphenoxy)methyl]-1-phenyl-1,2,3-triazole (7)
1-Benzyl-4-[(2,4-dichlorophenoxy)methyl]-1,2,3-triazole
M. p. 104 – 106 ◦C. – IR (KBr): νmax (cm−1) = 3141,
2910, 1594, 1510, 1461, 1370, 1230, 1109, 1041. – 1H NMR
(400 MHz, CDCl3): δ = 8.07 (s, 1H, 9-H), 7.77 – 7.74 (dd,
J = 1.6, 7.2 Hz, 2H, 11, 15-H), 7.54 (t, J = 7.2 Hz, 2H, 12,
14-H), 7.46 (dd, J = 1.6, 7.2 Hz, 1H, 13-H), 7.23 (t, J =
8.0 Hz, 1H, 5-H), 6.65 (dd, J = 2.4, 8.0 Hz, 1H, 6-H), 6.61
(t, J = 2.4 Hz, 1H, 2-H), 6.57 (dd, J = 2.4, 8.0 Hz, 1H, 4-H),
5.30 (s, 2H, 7-H), 3.81 (s, 3H, -OMe). – 13C NMR (100 MHz,
CDCl3): δ = 160.9, 159.5, 144.8, 136.9, 130.1, 129.8, 128.9,
121.1, 120.5, 107.0, 106.8, 101.3, 61.9, 55.3. – MS (ESI):
m/z (%) = 282 (100) [M+H]+. – HRMS ((+)-ESI): m/z =
282.1243 (calcd. 282.1238 for C16H16N3O2, [M+H]+).
(11)
M. p. 88 – 90 ◦C. – IR (KBr): νmax (cm−1) = 3142, 3036,
2928, 1586, 1485, 1468, 1289, 1249, 1103, 1066. – 1H NMR
(400 MHz, CDCl3): δ = 7.59 (s, 1H, 9-H), 7.40 – 7.37 (m,
3H, 13, 14, 15-H), 7.36 (d, J = 2.8 Hz, 1H, 3-H), 7.30 (dd,
J = 2.8, 6.8 Hz, 2H, 12, 16-H), 7.18 (dd, J = 2.4, 8.8 Hz,
1H, 5-H), 7.05 (d, J = 8.8 Hz, 1H, 6-H), 5.55 (s, 2H, 10-H),
5.26 (s, 2H, 7-H). – 13C NMR (100 MHz, CDCl3): δ =
152.5, 143.7, 134.5, 123.0, 129.1, 128.8, 128.1, 127.7, 126.4,
123.8, 123.1, 115.1, 63.4, 54.2. – MS (ESI): m/z (%) = 334
(100) [M+H]+. – HRMS ((+)-ESI): m/z = 334.0511 (calcd.
334.0514 for C16H14Cl2N3O, [M+H]+).
1-Benzyl-4-[(4-methoxyphenoxy)methyl]-1,2,3-triazole (8)
4-[(2,4-Dichlorophenoxy)methyl]-1-phenyl-1,2,3-triazole
(12)
M. p. 86 – 88 ◦C. – IR (KBr): νmax (cm−1) = 3124, 3082,
2948, 2928, 2831, 1510, 1454, 1233, 1119, 1048. – 1H
M. p. 117 – 119 ◦C. – IR (KBr): νmax (cm−1) = 3156,
NMR (400 MHz, CDCl3): δ = 7.52 (s, 1H, 9-H), 7.40 – 3096, 3034, 2921, 2874, 1739, 1291, 1596, 1506, 1491,
7.37 (m, 3H, 13, 14, 15-H), 7.29 – 7.26 (dd, J = 2.8, 7.2 Hz, 1451, 1248, 1105, 1059, 1043. – 1H NMR (400 MHz,
Unauthenticated
Download Date | 10/9/15 3:12 PM